Follow
F Blackhall
F Blackhall
University of Manchester
Verified email at christie.nhs.uk
Title
Cited by
Cited by
Year
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
AT Shaw, DW Kim, K Nakagawa, T Seto, L Crinó, MJ Ahn, T De Pas, ...
New England Journal of Medicine 368 (25), 2385-2394, 2013
37492013
First-line crizotinib versus chemotherapy in ALK-positive lung cancer
BJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ...
N Engl j Med 371, 2167-2177, 2014
31482014
Tracking the evolution of non–small-cell lung cancer
M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ...
New England Journal of Medicine 376 (22), 2109-2121, 2017
18002017
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ...
Nature 545 (7655), 446-451, 2017
13532017
Evaluation and prognostic significance of circulating tumor cells in patients with non–small-cell lung cancer
MG Krebs, R Sloane, L Priest, L Lancashire, JM Hou, A Greystoke, ...
Journal of clinical oncology 29 (12), 1556-1563, 2011
9682011
Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer
JM Hou, MG Krebs, L Lancashire, R Sloane, A Backen, RK Swain, ...
J Clin Oncol 30 (5), 525-532, 2012
8862012
Allele-specific HLA loss and immune escape in lung cancer evolution
N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ...
Cell 171 (6), 1259-1271. e11, 2017
8742017
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
CL Hodgkinson, CJ Morrow, Y Li, RL Metcalf, DG Rothwell, F Trapani, ...
Nature medicine 20 (8), 897-903, 2014
7102014
Molecular analysis of circulating tumour cells—biology and biomarkers
MG Krebs, RL Metcalf, L Carter, G Brady, FH Blackhall, C Dive
Nature reviews Clinical oncology 11 (3), 129-144, 2014
6282014
Osimertinib in pretreated T790M-positive advanced non-small-cell lung cancer: AURA study phase II extension component.
JC Yang, MJ Ahn, DW Kim, SS Ramalingam, LV Sequist, S Wc, SW Kim, ...
Journal of Clinical Oncology, 1288-1296, 2017
5122017
Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and-independent approaches
MG Krebs, JM Hou, R Sloane, L Lancashire, L Priest, D Nonaka, TH Ward, ...
Journal of thoracic oncology 7 (2), 306-315, 2012
5002012
Circulating tumor cells as a window on metastasis biology in lung cancer
JM Hou, M Krebs, T Ward, R Sloane, L Priest, A Hughes, G Clack, ...
The American journal of pathology 178 (3), 989-996, 2011
4892011
Fc effector function contributes to the activity of human anti-CTLA-4 antibodies
FA Vargas, AJS Furness, K Litchfield, K Joshi, R Rosenthal, E Ghorani, ...
Cancer cell 33 (4), 649-663. e4, 2018
4202018
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
C Faivre-Finn, M Snee, L Ashcroft, W Appel, F Barlesi, A Bhatnagar, ...
The Lancet Oncology 18 (8), 1116-1125, 2017
3872017
Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors
FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ...
Immunity 46 (4), 577-586, 2017
3342017
Three-gene prognostic classifier for early-stage non–small-cell lung cancer
SK Lau, PC Boutros, M Pintilie, FH Blackhall, CQ Zhu, D Strumpf, ...
Journal of Clinical Oncology 25 (35), 5562-5569, 2007
3092007
K-ras mutations in non-small-cell lung carcinoma: a review
S Aviel-Ronen, FH Blackhall, FA Shepherd, MS Tsao
Clinical lung cancer 8 (1), 30-38, 2006
3062006
Final overall survival analysis from a study comparing first-line crizotinib versus chemotherapy in ALK-mutation-positive non-small-cell lung cancer
BJ Solomon, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ...
J Clin Oncol 36 (22), 2251-2258, 2018
3002018
Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report
RS Irwin, CL French, AB Chang, KW Altman, TM Adams, E Azoulay, ...
Chest 153 (1), 196-209, 2018
2992018
Circulating tumour cells: their utility in cancer management and predicting outcomes
MG Krebs, JM Hou, TH Ward, FH Blackhall, C Dive
Therapeutic advances in medical oncology 2 (6), 351-365, 2010
2972010
The system can't perform the operation now. Try again later.
Articles 1–20